Clinical trials
Completed Alzheimer Disease trials in Norway
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
23 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 2 |
| 2007 | 1 |
| 2008 | 1 |
| 2010 | 2 |
| 2011 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 4 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 23 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Norwegian Centre for Ageing and Health | 3 |
| GlaxoSmithKline | 2 |
| Novartis Pharmaceuticals | 2 |
| University Hospital of North Norway | 2 |
| University of Bergen | 2 |
| University of Southern Denmark | 2 |
| Anglia Ruskin University | 1 |
| Boehringer Ingelheim | 1 |
| GE Healthcare | 1 |
| Haukeland University Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alzheimer Disease | 23 |
| Dementia | 7 |
| Dementia, Vascular | 3 |
| Lewy Body Disease | 3 |
| Low Back Pain | 2 |
| Agnosia | 1 |
| Anxiety Disorders | 1 |
| Central Nervous System Diseases | 1 |
| Cognitive Dysfunction | 1 |
| Dementia, Multi-Infarct | 1 |
Trials
Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.